According to a study presented at the 2012 Annual Meeting of the Society for Cardiovascular Angiography and Interventions, many women are unaware of their risk for cardiovascular disease (CV), but a screening tool completed during their annual ob/gyn examination could change that.
According to a study presented at the 2012 Annual Meeting of the Society for Cardiovascular Angiography and Interventions ([SCAI]; May 9-12; Las Vegas, Nevada), many women are unaware of their risk of cardiovascular disease (CVD)-but a screening tool completed by women during their annual ob/gyn examination could change that. Ob/gyns serve as primary care providers for 20% of women.
The tool is the product of a joint initiative between SCAI's Women in Innovations program and the Abbott Vascular Women's Heart Health Initiative, launched in 2010 to improve awareness and prevention of CVD in women by involving gynecologists in screening and distributing educational materials about CVD.
During their ob/gyn appointment, women complete a 1-page survey about CVD risk factors-diabetes, blood pressure, smoking, family history of heart disease, high cholesterol, shortness of breath, chest pain, and pregnancy-related complications: preeclampsia, gestational diabetes, and gestational hypertension. Those who have more than 2 risk factors are sent a letter advising them to follow up with their physician.
Heart disease is the leading cause of death among women in the United States, and mortality from CVD is increasing by 1% per year among women between the ages of 35 to 40.
Mungee S, et al. Women's Heart Health Initiative: collaborative effort is the key. Presented at: 2012 Annual Meeting of the Society for Cardiovascular Angiography and Interventions (SCAI); May 9-12, 2012; Las Vegas, Nevada.
Adverse maternal outcomes after uterine conservation in placenta accreta spectrum
May 9th 2024A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.
Read More
Barriers in seeking pelvic floor disorder treatment among ethnic minorities
May 8th 2024A recent shed light on how ethnic minority groups perceive pelvic floor disorders, highlighting barriers to treatment seeking and the importance of raising awareness about available treatment options.
Read More
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More